Phase I cancer trials: a crucible of competing priorities.
Miller
M
M
Department of Health Policy and Management, Harvard School of Public Health, 69 University Road, Brookline, MA 02445, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D017321:Clinical Trials, Phase I as Topic; D004992:Ethics, Medical; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D009369:Neoplasms / Q000188:drug therapy*; D010819:Physician's Role; D010817:Physician-Patient Relations; D012803:Sick Role
D000970:Antineoplastic Agents